Scientific Reports · 2017 · 16 citations · 18 references
Life SciencesMolecular BiologyOncologyCell SignalingGene ExpressionMolecular Cell BiologyCancer Cell SignalingCytokine Receptor SignalingInflammatory SignalingNuclear ReceptorsRetinoic Acid SignalingTumor Suppressor GenesAcute Promyelocytic LeukemiaNf-κb SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B InhibitionNuclear Factor Kappa B ModulationNuclear Factor Kappa B SignalingNuclear Translocation Of Transcription FactorsRetinoid Receptors
Abstract Promyelocytic Leukemia (PML) is a nuclear protein that forms sub-nuclear structures termed nuclear bodies associated with transcriptionally active genomic regions. PML is a tumour suppressor and regulator of cell differentiation. We demonstrate that PML promotes TNFα-induced transcriptional responses by promoting NF-κB activity. TNFα-treated PML −/− cells show normal IκBα degradation and NF-κB nuclear translocation but significantly reduced NF-κB DNA binding and phosphorylation of NF-κB p65. We also demonstrate that the PML retinoic acid receptor-α (PML-RARα) oncofusion protein, which causes acute promyelocytic leukemia, inhibits TNFα induced gene expression and phosphorylation of NF-κB. This study establishes PML as an important regulator of NF-κB and demonstrates that PML-RARα dysregulates NF-κB.
18
Role of PML in Cell Growth and the Retinoic Acid Pathway
Zhu Gang Wang, Laurent Delva, Mirella Gáboli et al. · Science · 1998 · 515 citations
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Joost H.A. Martens, Arie B. Brinkman, Femke Simmer et al. · Cancer Cell · 2010 · 295 citations · Full text